Posts Tagged ‘coronavirus

February 08, 2021
Our Take: HCA, insurers report billions in profits for 2020, though some saw decline in Q4
Read More
February 01, 2021
Our Take: Leading drugmakers persist in the battle against COVID-19
Read More
January 25, 2021
Our Take: UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020
Read More
January 18, 2021
Our Take: CMS announces NextGen ACO results — and they are impressive
Read More
January 11, 2021
Our Take: The demise of a proclaimed disrupter: Haven comes to a halt
Read More
January 04, 2021
Our Take: Pharma companies sign spate of deals before year-end
Read More
December 21, 2020
Our Take: 2020’s (other) top stories
Read More
December 14, 2020
Our Take: Pfizer, BioNTech nab first FDA authorization of a COVID-19 vaccine
Read More
December 07, 2020
Our Take: CMS reverses course, issues final rule to update Stark Law
Read More
November 23, 2020
Our Take: Amazon rattles the pharmacy industry with its long-awaited launch
Read More
November 16, 2020
Our Take: Pfizer’s COVID-19 vaccine demonstrates more than 90% efficacy, early data show; Lilly’s antibody drug is first to receive EUA
Read More
September 14, 2020
Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine
Read More
August 31, 2020
Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash
Read More
August 24, 2020
Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Posts Tagged ‘coronavirus

Our Take: HCA, insurers report billions in profits for 2020, though some saw decline in Q4

Our Take: Leading drugmakers persist in the battle against COVID-19

Our Take: UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020

Our Take: CMS announces NextGen ACO results — and they are impressive

Our Take: The demise of a proclaimed disrupter: Haven comes to a halt

Our Take: Pharma companies sign spate of deals before year-end

Our Take: 2020’s (other) top stories

Our Take: Pfizer, BioNTech nab first FDA authorization of a COVID-19 vaccine

Our Take: CMS reverses course, issues final rule to update Stark Law

Our Take: Amazon rattles the pharmacy industry with its long-awaited launch

Our Take: Pfizer’s COVID-19 vaccine demonstrates more than 90% efficacy, early data show; Lilly’s antibody drug is first to receive EUA

Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine

Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash

Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘coronavirus

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives